[Federal Register Volume 64, Number 46 (Wednesday, March 10, 1999)]
[Notices]
[Pages 11924-11925]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 99-5910]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute on Drug Abuse; Notice of Closed Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice is hereby given of the following
meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute on Drug Abuse Special
Emphasis Panel, Basic Behavioral and Cognitive Science Research:
Approaches to the Study of HIV/AIDS and Drug Abuse.
Date: March 31, 1999.
Time: 8:30 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Crystal Gateway Marriott, 1700 Jefferson Davis Highway,
Arlington, VA 22202.
Contact Person: Marina L. Volkov, Special Assistant, Office of
Extramural Program Review, National Institute on Drug Abuse,
National Institutes of Health, DHHS 6001 Executive Boulevard, Room
3158, MSC 9547 Bethesda, MD 20892-9547, (301) 435-1433.
(Catalogue of Federal Domestic Assistance Program Nos. 93.277, Drug
Abuse Scientist Development Award for Clinicians, Scientist
Development Awards, and Research Scientist
[[Page 11925]]
Awards; 93.278, Drug Abuse National Research Service Awards for
Research Training; 93.279, Drug Abuse Research Programs, National
Institutes of Health, HHS)
Dated: March 4, 1999.
LaVerne Y. Stringfield,
Committee Management Officer, NIH.
[FR Doc. 99-5910 Filed 3-9-99; 8:45 am]
BILLING CODE 5140-01-M
